What is the newest anti-anxiety drug? A guide to recent developments
•
5 min read
In August 2023, the FDA approved Zurzuvae (zuranolone) for postpartum depression, marking one of the most recent and novel pharmacological advancements related to anxiety and depression. This development, alongside breakthrough designations for compounds like MM-120, indicates a new era for what is the newest anti-anxiety drug, moving beyond traditional classes toward more targeted approaches.
